June 01, 2014 - MM&M - Medical Marketing and Media

Print Issue: June 01, 2014

Why no Bad-Ad Program letters?

While two dozen enforcement letters were sent by FDA’s Office of Prescription Drug Promotion to pharma companies last year, up from 21 in 2012, none of the letters were prompted by the Bad Ad Program.